Who is sponsoring NCT01867580?

NCT01867580 is sponsored by KCI USA, Inc.

What drugs are being tested in NCT01867580?

Interventions in NCT01867580: V.A.C.Ulta with Prontosan instillation, V.A.C.Ulta without instillation.

What condition does NCT01867580 study?

NCT01867580 studies Wounds and Injuries.

Is NCT01867580 still recruiting?

NCT01867580 is currently completed. Last updated 27 November 2024.

Are results published for NCT01867580?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-11-27 · How we verify

NCT01867580

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective, Randomized, Multi-Center Trial Evaluating the Effectiveness of the V.A.C. Ulta Negative Pressure Wound Therapy System With V.A.C. VeraFlo Dressing System in Operatively Debrided Wounds

Completed NA Results posted Last updated 27 November 2024

What this trial tests

NA trial testing V.A.C.Ulta with Prontosan instillation in Wounds and Injuries in 181 participants. Completed in 1 November 2015.

Timeline

1 May 2013

Primary endpoint
1 August 2015

1 November 2015

Quick facts

Lead sponsor	KCI USA, Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	181
Start date	1 May 2013
Primary completion	1 August 2015
Estimated completion	1 November 2015
Sites	7 locations across United States

Drugs / interventions tested

V.A.C.Ulta with Prontosan instillation
V.A.C.Ulta without instillation

Conditions studied

Wounds and Injuries — all drugs for Wounds and Injuries →

Sponsor

KCI USA, Inc — full company profile →

Who can join

18 and older, any sex, with Wounds and Injuries. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Number of Inpatient Operating Room Debridements
Time frame: until the wound is deemed ready for closure or coverage by the investigator up to 64 days
Debridement in this outcome refers to surgical removal of non viable tissue performed in an operating room

Sponsor's own description

The purpose of this study is to examine the effectiveness of the Veraflo with Prontosan vs VAC in wounds that require operative debridement.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The impact of negative-pressure wound therapy with instillation on wounds requiring operative debridement: Pilot randomised, controlled trial.
Kim PJ, Lavery LA, Galiano RD, Salgado CJ, et al · · 2020 · cited 20× · PMID 32567234 · DOI 10.1111/iwj.13424

Verify or expand the search:

Other recruiting trials for Wounds and Injuries

Currently open trials in the same condition.

NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT05638581 — Trauma Resuscitation With Low-Titer Group O Whole Blood or Products · Phase 3 · recruiting
NCT05910567 — A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma · NA · recruiting
NCT06121661 — APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System · Phase 1 · recruiting

Other KCI USA, Inc trials

Trials by the same sponsor.

NCT05902793 — Evaluating the Efficacy and Safety of the VERAFLO™ Dressing Kit for Wound Bed Preparation in Open Wounds · NA · completed
NCT03722485 — Negative Pressure Wound Therapy With Instillation of Saline Solution Versus Collagenase Ointment in Full-thickness Wound · NA · terminated
NCT03274466 — Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01867580 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by KCI USA, Inc
Last refreshed: 27 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01867580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing